ProShare Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 162 filers reported holding HAEMONETICS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$829,153
+2.8%
9,256
-2.3%
0.00%
+50.0%
Q2 2023$806,361
+9.5%
9,471
+6.4%
0.00%0.0%
Q1 2023$736,558
-10.1%
8,901
-14.6%
0.00%
-33.3%
Q4 2022$819,454
+20.3%
10,419
+13.0%
0.00%0.0%
Q3 2022$681,000
+11.6%
9,219
-1.4%
0.00%
+50.0%
Q2 2022$610,000
-33.7%
9,353
-35.7%
0.00%0.0%
Q1 2022$920,000
+2.6%
14,547
-14.0%
0.00%0.0%
Q4 2021$897,000
+13.5%
16,916
+51.1%
0.00%0.0%
Q3 2021$790,000
-36.9%
11,192
-40.4%
0.00%
-50.0%
Q2 2021$1,251,000
+131.7%
18,779
+286.0%
0.00%
+100.0%
Q1 2021$540,000
-7.1%
4,865
-0.5%
0.00%0.0%
Q4 2020$581,000
+54.9%
4,889
+13.7%
0.00%0.0%
Q3 2020$375,000
+1.1%
4,299
+3.6%
0.00%0.0%
Q2 2020$371,000
-35.0%
4,148
-27.6%
0.00%
-50.0%
Q1 2020$571,000
-60.1%
5,730
-54.0%
0.00%
-42.9%
Q4 2019$1,430,000
+4.5%
12,449
+14.7%
0.01%
-12.5%
Q3 2019$1,368,000
+5.7%
10,849
+0.9%
0.01%0.0%
Q2 2019$1,294,000
+25.0%
10,749
-9.2%
0.01%
+33.3%
Q1 2019$1,035,000
-0.8%
11,834
+13.5%
0.01%
-14.3%
Q4 2018$1,043,000
-26.9%
10,422
-16.3%
0.01%
-30.0%
Q3 2018$1,427,000
+24.6%
12,451
-2.5%
0.01%
+25.0%
Q2 2018$1,145,000
+57.9%
12,764
+28.8%
0.01%
+60.0%
Q1 2018$725,000
+14.2%
9,909
-9.4%
0.01%
+25.0%
Q4 2017$635,000
+140.5%
10,932
+85.8%
0.00%
+100.0%
Q3 2017$264,000
+2.7%
5,883
-9.6%
0.00%
-33.3%
Q2 2017$257,000
-22.8%
6,507
-20.7%
0.00%0.0%
Q1 2017$333,000
-18.0%
8,207
-18.8%
0.00%
-25.0%
Q4 2016$406,000
+64.4%
10,109
+48.1%
0.00%
+33.3%
Q3 2016$247,000
-6.4%
6,826
-24.9%
0.00%0.0%
Q2 2016$264,000
-12.3%
9,094
+5.8%
0.00%
-25.0%
Q1 2016$301,000
-12.5%
8,594
-19.5%
0.00%0.0%
Q4 2015$344,000
+37.6%
10,682
+38.0%
0.00%0.0%
Q3 2015$250,000
-41.2%
7,740
-24.7%
0.00%
-33.3%
Q2 2015$425,000
-33.0%
10,276
-27.2%
0.01%
-14.3%
Q1 2015$634,000
+13.6%
14,114
-5.4%
0.01%
+16.7%
Q4 2014$558,000
-31.8%
14,922
-36.3%
0.01%
-45.5%
Q3 2014$818,000
-20.5%
23,425
-19.7%
0.01%
-15.4%
Q2 2014$1,029,000
-42.3%
29,175
-46.7%
0.01%
-40.9%
Q1 2014$1,782,000
+604.3%
54,692
+812.4%
0.02%
+450.0%
Q4 2013$253,000
-81.7%
5,994
-82.7%
0.00%
-87.9%
Q3 2013$1,385,000
-7.5%
34,723
-4.1%
0.03%
+13.8%
Q2 2013$1,497,00036,2110.03%
Other shareholders
HAEMONETICS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders